DUBLIN--(BUSINESS WIRE)--The "Capsule Endoscopy Market to 2027 - Global Analysis and Forecasts by Product; Formulation; End Users, and Geography" report has been added to ResearchAndMarkets.com's ...
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing ...
Phase I study of imetelstat (GRN163L) in combination with paclitaxel (P) and bevacizumab (B) in patients (pts) with locally recurrent or metastatic breast cancer (MBC). Methods: In this randomized, ...
The tablet formulation of Brukinsa is supplied as a 160mg dose, allowing patients the convenience of taking only 2 tablets daily. The Food and Drug Administration (FDA) has approved a new tablet ...
Perrigo received final approval to manufacture Omeprazole Magnesium Delayed-Release Mini Capsules, 20mg. A mini capsule formulation of omeprazole magnesium delayed-release will be available ...
Clinical pharmacokinetics of simotinib, an oral EGFR tyrosine kinase inhibitor,in patients with advanced NSCLC patients. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results